Muutke küpsiste eelistusi

E-raamat: Handbook of Evidence-Based Pharmacist Care: Clinical, Economic, and Humanistic Impacts: Volume 2: Endocrine, Respiratory, and Renal Diseases and Disorders

  • Formaat: PDF+DRM
  • Ilmumisaeg: 21-Apr-2026
  • Kirjastus: Apple Academic Press Inc.
  • Keel: eng
  • ISBN-13: 9781040919576
Teised raamatud teemal:
  • Formaat - PDF+DRM
  • Hind: 182,00 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
Handbook of Evidence-Based Pharmacist Care: Clinical, Economic, and Humanistic Impacts: Volume 2: Endocrine, Respiratory, and Renal Diseases and DisordersSuurem pilt
  • Formaat: PDF+DRM
  • Ilmumisaeg: 21-Apr-2026
  • Kirjastus: Apple Academic Press Inc.
  • Keel: eng
  • ISBN-13: 9781040919576
Teised raamatud teemal:

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

Recognizing that the value of pharmacists extends beyond clinical interventions to include cost-effective healthcare solutions and compassionate patient-centered care, this new series of handbooks showcases the expanded roles and responsibilities of pharmacists. It is the first of its kind to provide comprehensive information about evidence-based pharmacist care across a wide range of healthcare issues, providing the latest research, guidelines, and up-to-date best practices.

Volume 2: Endocrine, Respiratory, and Renal Diseases and Disorders

focuses on the nuanced world of endocrine, respiratory, and renal diseases and disorders. It systematically explores various disease states, from diabetes to chronic kidney disease, emphasizing the critical role pharmacists play in optimizing clinical outcomes, ensuring economic efficiency, and enhancing the humanistic aspects of patient care. The volume covers types 1 and 2 diabetes, thyroid disorders, asthma, COPD, rhinitis, cystic fibrosis, acute and chronic kidney disease, glomerulonephritis, and renal dialysis.

VOLUMES IN HANDBOOKS OF EVIDENCE-BASED PHARMACIST CARE

Volume 1: Cardiovascular Diseases

Volume 2: Endocrine, Respiratory, and Renal Diseases and Disorders

Volume 3: Gastrointestinal Diseases and Disorders

Volume 4: Arthritis and Psychiatric Diseases and Disorders

Volume 5: System-Specific Infections

Volume 6: Widespread and Transmissible Infections

Volume 7: Skin Diseases and Conditions

Volume 8: Neurological, Hematological, and Urological Diseases and Disorders

Volume 9: Oncological Diseases and Disorders

Volume 10: Diseases and Disorders of Special Populations

Volume 11: Pharmacist Care in Special Services

Volume 12: Advanced Practices in Pharmacist Care

Volume 13: Pharmacist Skills and Competencies

Volume 14: Clinical Pharmacy, Advanced Pharmacist Practice, and Pharmacy Clinics: Case Studies from Around the World

 



Focuses on endocrine, respiratory, and renal diseases and disorders and the multifaceted impact of pharmacist care. Covers types 1 and 2 diabetes, thyroid disorders, asthma, COPD, rhinitis, cystic fibrosis, acute and chronic kidney disease, glomerulonephritis, and renal dialysis

1. Evidence-Based Pharmacist Care (Clinical, Economic, andHumanistic
Impact): Type 2 Diabetes
2. Evidence-Based Pharmacist Care (Clinical,
Economic, andHumanistic Impact): Thyroid Disorders
3. Evidence-Based
Pharmacist Care (Clinical, Economic, andHumanistic Impact): Asthma
4.
Evidence-Based Pharmacist Care (Clinical, Economic, andHumanistic Impact):
Rhinitis
5. Evidence-Based Pharmacist Care (Clinical, Economic, andHumanistic
Impact): Cystic Fibrosis Management
6. Evidence-Based Pharmacist Care
(Clinical, Economic, andHumanistic Impact): Acute Kidney Disease
7.
Evidence-Based Pharmacist Care (Clinical, Economic, andHumanistic Impact):
Glomerulonephritis 8.Evidence-Based Pharmacist Care (Clinical, Economic,
andHumanistic Impact): Renal Dialysis
Yaser Mohammed Al-Worafi, PhD, FRSPH (UK), is a Professor of Clinical Pharmacy at the College of Pharmacy, University of Science and Technology of Fujairah, United Arab Emirates. He has more than 20 years of experience in education, practice, research, and administration in Yemen, Saudi Arabia, United Arab Emirates, and Malaysia, having taught, prepared, designed, and written courses and programs for many universities on clinical pharmacy, pharmacy practice, social pharmacy, and patients care. He has authored over 100 peer-reviewed papers in international journals and book chapters and has edited more than 30 books. A fellow of the Royal Society of Public Health, UK, Prof. Yaser has been recognized globally for his contributions to pharmacy practice, education, and medication and patient safety and is listed as one of the Top 2% Scientists of the World by Stanford University. He is ranked among the best ten researchers globally in several key areas, highlighting his dedication and expertise in advancing medication safety and effectiveness.
Lisainfo e-raamatute kohta Lisainfo e-raamatute kohta
Püsilink: https://www.kriso.ee/db/97810409195762e.html
Märksõnad: